Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co Portfolio 13F
Ronald Muhlenkamp Holdings Activity
- Portfolio value:
- $472.94M≈ (-$22M≈)
- Previous value:
- $495.00M≈
- # of changes:
- 62
- New positions:
- 7
- Reported for:
- 31 Mar 2015 (Q1)
- Latest filing date:
- 14 May 2015
Muhlenkamp & Co has disclosed a total of 62 changes to the portfolio in the (2015 Q1) SEC report(s): increased the number of shares of 23, bought 7 totally new, decreased the number of shares of 24 and completely sold out 8 position(s).
What stocks did Ronald Muhlenkamp buy in 2015 Q1?
During 2015 Q1 Ronald Muhlenkamp has bought 30 securities out of which top 5 purchases (by % change to portfolio) were (AAPL) Apple Inc (added shares +0.12%), (LNC) Lincoln National Corp (added shares +0.02%), (ON) ON Semiconductor Corp (added shares +149.26%), (CE) Celanese Corp (added shares +0.02%) and (MDT) Medtronic PLC (new buy).
In the 2015 Q1 report(s) the following changes have been made to the top investments: (BFH) Bread Financial Holdings, Inc (reduced shares -0.11%), (JPM) JPMorgan Chase & Co (reduced shares -0.83%), (GILD) Gilead Sciences Inc (reduced shares -0.09%), (DCH) DAUCH CORP (reduced shares -2.03%) and (AAPL) Apple Inc (added shares +0.12%).
62 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ATHERSYS INC
|
new
|
$71.43
|
-100.00%($0.00)
|
0.01%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
Baker Hughes Inc
|
new
|
$63.58
|
|
1.49%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
Cigna Corp
|
new
|
$129.52
|
+108.47%($270.02)
|
0.06%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
Epizyme Inc
|
new
|
$18.78
|
|
0.21%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
Genworth Financial Inc
|
new
|
$7.30
|
+33.38%($9.73)
|
0.04%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
Medtronic PLC
|
new
|
$77.99
|
+9.95%($85.74)
|
2.86%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
NOBLE CORP ORD SHS (CHE)
|
new
|
$14.29
|
|
0.04%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
Halliburton Company
|
+811.03%
|
$43.88
|
-27.31%($31.90)
|
1.04%
|
2013 Q2 or earlier
|
≈ 2.00+ years
|
||||
|
|
MacroGenics Inc
|
+297.04%
|
$31.37
|
-87.57%($3.90)
|
0.44%
|
2014 Q3
|
≈ 0.75 years
|
||||
|
|
ON Semiconductor Corp
|
+149.26%
|
$12.11
|
+543.92%($77.98)
|
3.25%
|
2014 Q3
|
≈ 0.75 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.